D-Rd in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes D-Rd in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes April 2025 Clinical trials Read more
2020 April EHA 2019 Brentuximab vedotin + AVD provides durable benefit in Hodgkin’s lymphoma patients Read more
2020 April EHA 2019 Acalabrutinib delays disease progression in patients with relapsed/refractory CLL Read more
2020 April EHA 2019 Voxelotor induces robust improvements in anemia in patients with sickle cell disease Read more
Top
